Alzheimer’s Blood Test Cleared for Primary Care Use

By News Health
4 hours Ago

(MedPage Today) — FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer’s disease and other causes of cognitive decline that can be used in the primary care setting, Roche announced…

Source link : https://www.medpagetoday.com/neurology/alzheimersdisease/117920

Author :

Publish date : 2025-10-13 18:23:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Radiation-Free Approach Promising for Some Locally Advanced Lung Cancers

HES Volume Expander Comes Back With Redeeming Safety Data

Alpha-Gal Syndrome: What to Know

Many Young Adults Use Cannabis or Booze as a Sleep Aid

Prescription Drug Coverage Options Are Shrinking for Medicare Shoppers

FDA Adds Boxed Warning for IEC-EC to CAR-T Drug